3ZHANG Jian-guo,ZHANG Kai,WANG Zhong-cheng,GE Ming and MA Yu Department of Neurosurgery,Beijing Tiantan Hospital,Capital University of Medical Sciences,Functional Neurosurgical Department,Beijing Neurosurgical Institute,Beijing 100050,China.Deep brain stimulation in the treatment of secondary dystonia[J].Chinese Medical Journal,2006(24):2069-2074. 被引量：9
4Bai YM,Chou KH,Lin CP,et al.White matter abnormalities in schizophrenia patients with tardive dyskinesia:A diffision image study[J].Schizophr Res,2009,109(2-3):161-181.
5Tanaka Y,Koizumi C,Marumo T,et al.Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models[J].Life Sci,2007,81(8):657-663.
6Rothermundt M,Ohrmann P,Abel S,et al.Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol[J].Prog Neuropsychopharmacol Biol Psychiatry,2007,31(2):361-364.
7Zhang XY,Xiu MH,Chen DC,et al.Increased S100B serum levels in schizophrenic patients with tardive dyskinesia:association with dyskinetic movements[J].J Psychiatr Res,2010,44(7):429-433.
8Schooler NR,Kane JM.Research diagnoses for tardive dyskinesia[J].Arch Gen Psychiatry,1982,39(4):486-487.
9Miller DD,McEvoy JP,Davis SM,et al.Clinical correlates of tardive dyskinesia in schizophrenia:baseline data from the CATIE schizophrenia trial[J].Schizophr Res,2005,80(1):33-34.
10Correll CU,Schenk EM.Tardive dyskinesia and new antipsychotics[J].Curr Opin Psychiatry,2008,21(2):151-156.
